Tuberc Respir Dis > Volume 69(6); 2010 > Article
Tuberculosis and Respiratory Diseases 2010;69(6):474-479.
DOI: https://doi.org/10.4046/trd.2010.69.6.474    Published online December 1, 2010.
Levofloxacin and Torsades de Pointes.
Se Ah Kwon, Cheol Hong Kim, Won Jun Song, Ja Kyung Koo, Soon Jae Lee, Ji Young Park, In Gyu Hyun, Jang Hyu Ko, Hyun Soo Kim
1Department of Internal Medicine, Hallym University College of Medicine, Seoul, Korea. kimch2002@hallym.or.kr
2Department of Plastic and Reconstructive Surgery, Hallym University College of Medicine, Seoul, Korea.
3Department of Laboratory Medicine, Hallym University College of Medicine, Seoul, Korea.
Abstract
Torsades de pointes associated with a prolonged QT interval is a life-threatening arrhythmia, which may be induced by any of the following: drugs, electrolyte imbalances, severe bradycardia and intracranial hemorrhage. Torsades de pointes is characterized by beat-to-beat variations in the QRS complexes in any ECG leads with rates of 200~250 per minute. Fluoroquinolones are widely used and well tolerated antibacterial agents. However, prolongation of the QT interval leads rarely to Torsades de pointes as a significant adverse effect. So, it should be used with caution in high-risk patients for developing Torsades de pointes. We report one case of 67-year old man with contact burns who experienced Torsades de pointes, which probably resulted from the use of levofloxacin, and no further episode occurred after its withdrawal.
Key Words: levofloxacin, Torsades de Pointes
TOOLS
METRICS Graph View
  • 0 Crossref
  •   Scopus
  • 2,341 View
  • 19 Download
Related articles


ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail: katrdsubmit@lungkorea.org                

Copyright © 2024 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next